TARS

Tarsus Pharmaceuticals, Inc.NASDAQHealthcare

$70.12-0.14%ClosedMarket Cap: $2.98B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-02-25	Guggenheim	—	Buy	—
2026-02-25	Oppenheimer	—	Outperform	—
2025-11-05	Guggenheim	—	Buy	—
2025-10-20	HC Wainwright & Co.	—	Buy	—
2025-05-05	Goldman Sachs	—	Neutral	—
2025-05-02	Guggenheim	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$3.06	$901.2M	4
Sun Dec 31	$5.09	$1.06B	4
Mon Dec 31	$7.00	$1.20B	2
Tue Dec 31	$9.20	$1.33B	2